Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Capital Markets

Keurig Dr Pepper  / Equity Capital Markets

<ul><li>After nearly three years of the big merger, Keurig Dr Pepper has continued well on a decent growth trajectory despite the obvious inflationary and supply chain issues plaguing the consumer goods domain.</li><li>Sunkist continued to perform exceptionally well and Dr.</li><li>Pepper continues to post strong consumption growth.</li></ul>

After nearly three years of the big merger, Keurig Dr Pepper has continued well on a decent growth trajectory despite the obvious inflationary and supply chain issues plaguing the consumer goods domain.Sunkist continued to perform exceptionally well and Dr.Pepper continues to post strong consumption growth.

Keurig Dr Pepper Inc.: Brand Portfolio & Distribution

Credit

<ul><li>Keurig Dr Pepper went on with its high single-digit top-line growth trajectory in 2021 and saw growth in all key segments of the business after the management increased marketing investment by around 6.8%.</li><li>The food and beverage industry has been hit by rising input costs as a result of inflation and supply chain issues and Keurig Dr Pepper is no exception to this.</li><li>Baptista Research looks to evaluate the different credit strengths and credit risks of the company as well as a line-by-line analysis of the financial statements of the company for the past four years.</li></ul>

Keurig Dr Pepper went on with its high single-digit top-line growth trajectory in 2021 and saw growth in all key segments of the business after the management increased marketing investment by around 6.8%.The food and beverage industry has been hit by rising input costs as a result of inflation and supply chain issues and Keurig Dr Pepper is no exception to this.Baptista Research looks to evaluate the different credit strengths and credit risks of the company as well as a line-by-line analysis of the financial statements of the company for the past four years.

Keurig Dr Pepper: Detailed Credit Analysis & Financial Strength Evaluation Report

<ul><li>Keurig Dr Pepper’s stock has had a relatively smooth trajectory for most of 2021 as the company has continued with its high-single-digit top-line.</li><li>The company did see an upside in the cold beverage retail base fueled by a favorable net price realization of 3.6% and a higher volume mix of 3.2%.</li><li>The in-market performance of KDP’s cold beverages was strong and it saw a staggering 22% growth in the sales of brewers.</li></ul>

Keurig Dr Pepper’s stock has had a relatively smooth trajectory for most of 2021 as the company has continued with its high-single-digit top-line.The company did see an upside in the cold beverage retail base fueled by a favorable net price realization of 3.6% and a higher volume mix of 3.2%.The in-market performance of KDP’s cold beverages was strong and it saw a staggering 22% growth in the sales of brewers.

Keurig Dr Pepper Inc.: Financial & Price Forecasts, DCF Valuation, Risk Factors (03/22)

Value Investing

Vladimir Dimitrov, CFA

Equity Bottom-Up

<ul>
<li>Coca-Cola's share price continues to outperform, while it is still attractively priced relative to peers.</li>
<li>High free cash flow generation and industry leading profitability set the company apart, even from the other leaders in beverages.</li>
<li>Although the company's strong international exposure results in lower return on capital, it offers a major competitive advantage.</li>
</ul>


Coca-Cola's share price continues to outperform, while it is still attractively priced relative to peers.
High free cash flow generation and industry leading profitability set the company apart, even from the other leaders in beverages.
Although the company's strong international exposure results in lower return on capital, it offers a major competitive advantage.


<ul><li>Keurig Dr Pepper’s stock has been on a flat trajectory as the company delivered another quarter with a decent net sales growth of 6.8% with fair gains across all business categories.</li><li>The company’s single-serve coffee pods have also seen a decent sales growth (4.3% in the last quarter).</li><li>Overall, we remain optimistic about Keurig Dr Pepper and maintain a 'Hold' rating with a revised target price.</li></ul>

Keurig Dr Pepper’s stock has been on a flat trajectory as the company delivered another quarter with a decent net sales growth of 6.8% with fair gains across all business categories.The company’s single-serve coffee pods have also seen a decent sales growth (4.3% in the last quarter).Overall, we remain optimistic about Keurig Dr Pepper and maintain a 'Hold' rating with a revised target price.

Keurig Dr Pepper: A Consistent Performer (12/2021)

United States

Keurig Dr Pepper Inc. manufactures and distributes non-alcoholic beverages. The Company offers soft drinks, juices, teas, mixers, water, and other beverages. Keurig Dr Pepper serves customers in the United States, Canada, and Mexico.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Keurig Dr Pepper (KDP US)

Keurig Dr Pepper Inc.: Brand Portfolio & Distribution

After nearly three years of the big merger, Keurig Dr Pepper has continued well on a decent growth trajectory despite the obvious inflationary and...

Baptista Research

Keurig Dr Pepper: Detailed Credit Analysis & Financial Strength Evaluation Report

Keurig Dr Pepper went on with its high single-digit top-line growth trajectory in 2021 and saw growth in all key segments of the business after...

Baptista Research

Keurig Dr Pepper Inc.: Financial & Price Forecasts, DCF Valuation, Risk Factors (03/22)

Keurig Dr Pepper’s stock has had a relatively smooth trajectory for most of 2021 as the company has continued with its high-single-digit...

Baptista Research

Coca-Cola: Still Holding The Crown

Coca-Cola's share price continues to outperform, while it is still attractively priced relative to peers. High free cash flow generation and...

Vladimir Dimitrov, CFA

Keurig Dr Pepper: A Consistent Performer (12/2021)

Keurig Dr Pepper’s stock has been on a flat trajectory as the company delivered another quarter with a decent net sales growth of 6.8% with fair...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)